SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-037681
Filing Date
2008-06-17
Accepted
2008-06-17 19:08:56
Documents
2
Period of Report
2008-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4088
2 POA DOCUMENT poa.txt EX-24.4_246250 3856
  Complete submission text file 0001209191-08-037681.txt   9932
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O REGENERX BIOPHARMACEUTICALS, INC 3 BETHESDA METRO CENTER - SUITE 630 BETHESDA MD 20814
Business Address 301-280-1992
Lyons C Neil (Reporting) CIK: 0001324648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 08904313